0KW4.LSE ResMed Inc.

Healthcare Commercial Services & Supplies London Exchange
- USD
Market cap
-
P/E
44.1x
P/B
-
ROE
28.1%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Sep 2026.

Is 0KW4.LSE undervalued?

Graham number

The Graham number of ResMed Inc. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

ResMed Inc. fundamental analysis

No fundamental analysis for ResMed Inc. yet.

ResMed Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About ResMed Inc.

ResMed Inc. engages in the digital health and cloud-connected medical devices business in the United States and internationally. It operates in two segments, Sleep and Breathing Health, and Residential Care Software. The company offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl…

Full company profile